Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.
Who will be affected?
Readers: No access to all 28 journals. We recommend accessing our articles via PubMed Central
Authors: No access to the submission form or your user account.
Reviewers: No access to your user account. Please download manuscripts you are reviewing for offline reading before Wednesday, July 01, 2020 at 7:00 PM.
Editors: No access to your user account to assign reviewers or make decisions.
Copyeditors: No access to user account. Please download manuscripts you are copyediting before Wednesday, July 01, 2020 at 7:00 PM.
Ghelfi L, Healy J, Piacenza F, French I, McNamara N, Rabbi KA, Bond B, O'Hora E, Roddy D, Kamali M, Das S, Just SA, Tedeschi E, Hussain M, Mikalsen KÃ, Kaiser S, Cecere G, Koops S, de Boer J, Nguyen E, Bora E, Hinzen W, Homan P, Sommer IE, Cotter D, Cannon M, Lyne JP
Using AI to Detect Psychosis Relapse: Scoping Review
Using Artificial Intelligence to Detect Relapse of Psychosis: A Scoping Review
Lorenzo Ghelfi;
Jack Healy;
Francesco Piacenza;
Ian French;
Nicholas McNamara;
Khyber Afridi Rabbi;
Benjamin Bond;
Emma O'Hora;
Darren Roddy;
Moyyad Kamali;
Sudipto Das;
Sandra Anna Just;
Enrico Tedeschi;
Musarrat Hussain;
Karl Øyvind Mikalsen;
Stefan Kaiser;
Giacomo Cecere;
Sanne Koops;
Janna de Boer;
Elysie Nguyen;
Emre Bora;
Wolfram Hinzen;
Philipp Homan;
Iris E. Sommer;
David Cotter;
Mary Cannon;
John Paul Lyne
ABSTRACT
Background:
Psychotic disorder represents a leading cause of disability worldwide, and relapse in psychosis is common. Artificial intelligence (AI) is increasingly recognized as a method which could aid clinical monitoring in psychosis.
Objective:
This scoping review aims to identify studies which have used methods with an AI component to detect relapse in psychosis.
Methods:
A systematic search strategy was conducted on PubMed, PsycINFO and Embase from inception to January 2026. Observational studies, randomized controlled trials and quasi-experimental studies which used AI methods to detect relapse in psychosis were eligible for inclusion. Screening and data extraction procedures were conducted by at least two reviewers working independently. Findings were extracted, charted and described using narrative synthesis based on data extraction and consensus meetings with the research team. The scoping review was prospectively registered with Open Science Framework.
Results:
Relevant studies identified (n = 10) included use of digital tools such as smartphone and smartwatch-based monitoring, ecological momentary assessment tools, social media activity and internet searches. Digital phenotyping via smartphones and wearables emerged as the most common method for data collection. Efficacy of AI models varied with sensitivity (or recall) ranging from 0.25 to 0.77 and specificity ranging from 0.06 to 0.88. Reported area under the receiver operating characteristic curve for models ranged from 0.63 to 0.78. AI models were heterogenous across studies, and most study findings were not replicated.
Conclusions:
This scoping review highlights both the promise and current limitations of AI in psychosis relapse prediction. Digital phenotyping research in detection of psychosis relapse has progressed, but future studies need to include larger numbers of participants and should incorporate other methods such as use of large language models. Future studies will require large collaborations aiming to deliver AI tools for use in real world clinical practice. Clinical Trial: N/A
Citation
Please cite as:
Ghelfi L, Healy J, Piacenza F, French I, McNamara N, Rabbi KA, Bond B, O'Hora E, Roddy D, Kamali M, Das S, Just SA, Tedeschi E, Hussain M, Mikalsen KÃ, Kaiser S, Cecere G, Koops S, de Boer J, Nguyen E, Bora E, Hinzen W, Homan P, Sommer IE, Cotter D, Cannon M, Lyne JP
Using AI to Detect Psychosis Relapse: Scoping Review